Skip to main content
Contact Us
Subscribe
E-Edition
55°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
TRACON Pharmaceuticals, Inc. - Common Stock
(NQ:
TCON
)
1.430
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TRACON Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
TRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023
October 31, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 27, 2023
Gainers NKGen Biotech, Inc. (NASDAQ: NKGN) shares surged 60.9% to $6.08 in pre-market trading after gaining 8% on Thursday. NKGen Biotech presented Phase I clinical trial data at the 16th Annual...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
October 27, 2023
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!
Via
InvestorPlace
A Preview Of TRACON Pharma's Earnings
August 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 13, 2023
Via
Benzinga
Why Pioneer Natural Resources Shares Are Bouncing By Around 12%; Here Are 20 Stocks Moving Premarket
October 06, 2023
Gainers Vaccinex, Inc. (NASDAQ: VCNX) shares rose 40.2% to $1.15 in pre-market trading as two large insider buys were reported after the close on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
October 06, 2023
We're starting off Friday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
September 29, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
Friday's session saw 112 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 21, 2023
Via
Benzinga
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
September 18, 2023
Full ENVASARC accrual expected in Q4 and final data expected in mid-2024
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
September 05, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
August 25, 2023
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
August 21, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via
Benzinga
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 14, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
August 02, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
July 21, 2023
Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 21, 2023
It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
July 11, 2023
Collection of Award Extends Cash Runway into early 2024 and Past Expected Full Accrual of the ENVASARC Pivotal Trial
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
What's Going On With TRACON Pharmaceuticals Shares Today
June 20, 2023
TRACON Pharmaceuticals (NASDAQ: TCON) shares are trading lower Thursday morning after the company released the results of a six-month independent data monitoring committee (IDMC) review for the...
Via
Benzinga
TRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial
June 20, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
TRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference
June 16, 2023
From
TRACON Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.